SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?


To: Henry Niman who wrote (11161)11/15/1997 2:44:00 PM
From: medsunman  Read Replies (3) | Respond to of 32384
 
IMO Courtney was expressing frustration with the fact that your comments re LGND seem to lack balance. No matter what happens, "it is good for LGND." If the stock moves up 1/16, it because the big boys are buying. If it goes down, weak hands are being cleared out. You always predict upward movement, citing $100 million up-front deals that don't happen, mergers that don't take place, new analyst coverage that never appears, articles in the popular press that are never published, etc., etc., etc. Anyone reading this thread seeking balanced info from which to make an investment decision will be sorely disappointed. Then you go to great lengths to denigrate the competition, such as AMLN. When they announced their first two Phase III trials, you posted dozens of messages emphasizing every possible negative nuance. I suppose TonyT could have come here and done the same when the Lilly deal was finally announced, but he didn't. When you hype this stock and attack others, I think you invite this sort of criticsm.